YI, Zile. Inhibition of integrin receptor by increasing concentrations and treatment durations with Cilengitide increases the sensitivity of killing in vivo of U87 glioma cancer cell xenograft mouse. MedScien, [S. l.], v. 2, n. 1, p. 382, 2024. DOI: 10.61173/hsv29020. Disponível em: https://ms.deanfrancis.press/article/view/1269. Acesso em: 4 nov. 2026.